C.R. Bard to Pay $184M in Hernia Patch Suits
C.R. Bard, parent company to Davol Inc., has reached a $184 million settlement involving more than 2,600 lawsuits filed against the company for medical complications caused by the company’s Composix Kugel Mesh hernia patch. Thousands of plaintiffs claimed the defective hernia patch, used to treat hernias, caused them grave personal injuries including:
- bowel perforation
- intestinal fistulas
- abdominal abscess formations
Class 1 Recall
The Food and Drug Administration (FDA) issued a Class 1 recall of the patch in 2005 after finding the “memory recoil ring” that opens the patch could break under the stress of placement and cause rupture of the bowel and/or chronic intestinal fistulae (abnormal connections or passageways between the intestines and other organs).
- C.R. Bard paid $1.5 million to plaintiffs in 2010 in Christopher Thorpe and Laure Thorpe v. Davol, Inc. and C.R. Bard, Inc.
- Also in 2010- John Whitfield v. Davol, Inc., et al. resulted in no payout to the plaintiff
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of product liability litigation. Our Defective Drug and Products Division has extensive knowledge and resources in order to represent our clients efficiently and aggressively. We represent a multitude of people who are battling against manufacturers of food, medical devices and defective pharmaceuticals.
Your choice does matter. If you or a loved one has suffered serious injuries because of any defective drugs and/or products, call Thomas J. Henry immediately. We are available 24/7, nights and weekends.